Why do pharmaceuticals cost so much?
11 de abr. de 2020 ·
16m 5s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
In this discussion, Andrew Satz, CEO and Daniel Gigante chat about the cost of pharmaceuticals. Andrew begins by detailing the major input required to not just bring a drug to...
mostra más
In this discussion, Andrew Satz, CEO and Daniel Gigante chat about the cost of pharmaceuticals. Andrew begins by detailing the major input required to not just bring a drug to market, but to protect it legislatively. He then covers how AI (read: EVQLV) can potentially reduce the cost of drug discovery.
With respect to EVQLV, Andrew feels the company can't eliminate any variables that factor into cost, but instead can mitigate the damage from specific variables.
Music: www.bensound.com/
For more information on EVQLV, check out our site here: www.evqlv.com/
mostra menos
With respect to EVQLV, Andrew feels the company can't eliminate any variables that factor into cost, but instead can mitigate the damage from specific variables.
Music: www.bensound.com/
For more information on EVQLV, check out our site here: www.evqlv.com/
Información
| Autor | Daniel Gigante |
| Organización | Daniel Gigante |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
